StockData
Agenus Inc logo

Agenus Inc (AGEN) stock

AGENNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 5, 2026Score 3/30
$6.29−0.44 (-6.54%)

Close on Nov 16, 2026Market cap $283.18MP/E –Yield –

Agenus gross margin

Gross margin is gross profit as a percentage of revenue.

Agenus's gross margin for the twelve months ending Jun 30, 2026 was 99.5%. For fiscal 2025 it was 99.1%, against 99.5% the year before. The highest annual figure on record is 100.0% in fiscal 2009.

Annual gross margin

PeriodPeriod endValueChange (pts)
FY2025Dec 31, 202599.1%−0.4
FY2024Dec 31, 202499.5%+1.5
FY2023Dec 31, 202398.0%+8.8
FY2022Dec 31, 202289.2%−9.6
FY2021Dec 31, 202198.8%+1.5
FY2020Dec 31, 202097.3%−2.7
FY2014Dec 31, 2014100.0%+17.6
FY2013Dec 31, 201382.4%−13.4
FY2012Dec 31, 201295.8%−4.2
FY2011Dec 31, 2011100.0%+3.7
FY2010Dec 31, 201096.3%−3.7
FY2009Dec 31, 2009100.0%–

Quarterly gross margin

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange (pts)
Q2 FY2026Jun 30, 2026100.0%+0.9
Q1 FY2026Mar 31, 2026100.0%+0.6
Q4 FY2025Dec 31, 2025100.0%+0.4
Q3 FY2025Sep 30, 202597.9%−1.5
Q2 FY2025Jun 30, 202599.1%−0.5
Q1 FY2025Mar 31, 202599.4%−0.2
Q4 FY2024Dec 31, 202499.6%−0.1
Q3 FY2024Sep 30, 202499.4%+0.7
Q2 FY2024Jun 30, 202499.5%+0.5
Q1 FY2024Mar 31, 202499.6%+9.6
Q4 FY2023Dec 31, 202399.7%+26.8
Q3 FY2023Sep 30, 202398.8%+0.1
Q2 FY2023Jun 30, 202399.0%+8.7
Q1 FY2023Mar 31, 202390.0%−7.9
Q4 FY2022Dec 31, 202272.9%−22.8
Q3 FY2022Sep 30, 202298.6%−1.0
Q2 FY2022Jun 30, 202290.3%−3.5
Q1 FY2022Mar 31, 202297.9%+7.3
Q4 FY2021Dec 31, 202195.7%−1.8
Q3 FY2021Sep 30, 202199.7%+5.8
Q2 FY2021Jun 30, 202193.8%−3.9
Q1 FY2021Mar 31, 202190.6%–
Q4 FY2020Dec 31, 202097.4%–
Q3 FY2020Sep 30, 202093.9%–
Q2 FY2020Jun 30, 202097.6%–

More Agenus figures

See a number that looks wrong?